Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 09 02:40PM ET
23.48
Dollar change
-0.13
Percentage change
-0.55
%
IndexRUT P/E- EPS (ttm)-5.00 Insider Own6.67% Shs Outstand124.38M Perf Week-10.86%
Market Cap3.09B Forward P/E- EPS next Y-3.32 Insider Trans-0.11% Shs Float116.14M Perf Month9.77%
Income-599.49M PEG- EPS next Q-0.69 Inst Own76.60% Short Float8.13% Perf Quarter9.36%
Sales3.55M P/S871.37 EPS this Y43.89% Inst Trans-0.51% Short Ratio6.81 Perf Half Y-4.20%
Book/sh1.49 P/B15.75 EPS next Y-18.30% ROA-62.93% Short Interest9.45M Perf Year-4.28%
Cash/sh5.17 P/C4.54 EPS next 5Y7.33% ROE-262.48% 52W Range17.05 - 39.83 Perf YTD-23.27%
Dividend Est.- P/FCF- EPS past 5Y- ROI-58.15% 52W High-41.05% Beta0.93
Dividend TTM- Quick Ratio6.74 Sales past 5Y-2.87% Gross Margin-423.66% 52W Low37.71% ATR (14)1.55
Dividend Ex-Date- Current Ratio6.74 EPS Y/Y TTM-160.68% Oper. Margin-16927.06% RSI (14)56.64 Volatility7.54% 6.67%
Employees609 Debt/Eq4.59 Sales Y/Y TTM-98.52% Profit Margin-16882.37% Recom1.77 Target Price43.67
Option/ShortYes / Yes LT Debt/Eq4.56 EPS Q/Q-34.15% Payout- Rel Volume0.52 Prev Close23.61
Sales Surprise-100.00% EPS Surprise-21.39% Sales Q/Q-100.00% EarningsNov 26 AMC Avg Volume1.39M Price23.48
SMA207.91% SMA5014.23% SMA200-3.14% Trades Volume582,928 Change-0.55%
Date Action Analyst Rating Change Price Target Change
Jun-05-24Initiated Goldman Neutral $31
Dec-04-23Initiated BofA Securities Buy $29
Sep-19-23Initiated Citigroup Neutral $33
Jul-21-23Initiated TD Cowen Outperform
May-12-23Downgrade SVB Securities Outperform → Market Perform $40
Apr-26-23Initiated SMBC Nikko Outperform $80
Apr-12-23Upgrade SVB Securities Market Perform → Outperform $21 → $35
Mar-21-23Initiated Bernstein Mkt Perform $27
Sep-09-22Initiated Morgan Stanley Equal-Weight $41
May-11-22Upgrade Robert W. Baird Neutral → Outperform $71 → $60
Dec-04-24 07:40AM
Dec-03-24 07:30AM
Dec-02-24 07:30AM
Nov-30-24 06:00AM
Nov-29-24 01:00AM
08:15AM Loading…
Nov-28-24 08:15AM
Nov-27-24 12:40PM
11:07AM
07:21AM
07:20AM
04:33AM
02:04AM
Nov-26-24 05:18PM
04:05PM
04:00PM
09:06AM Loading…
09:06AM
07:00AM
07:00AM
Nov-22-24 07:41AM
Nov-19-24 03:38AM
Nov-18-24 07:31AM
07:30AM
Nov-05-24 07:30AM
Nov-04-24 07:30AM
Nov-01-24 07:30AM
Oct-16-24 01:01PM
Oct-14-24 04:30PM
Oct-09-24 05:53PM
Sep-24-24 06:53AM
Sep-23-24 07:30AM
06:12AM Loading…
Sep-11-24 06:12AM
Sep-10-24 07:30AM
Sep-03-24 10:36AM
06:33AM
Sep-02-24 06:36AM
Aug-21-24 07:30AM
Aug-16-24 06:00AM
Aug-15-24 10:52AM
Aug-14-24 01:30PM
Aug-08-24 04:37PM
04:01PM
04:00PM
Jul-29-24 04:30PM
Jul-24-24 07:30AM
Jun-28-24 06:50AM
Jun-25-24 01:55PM
Jun-24-24 07:30AM
Jun-03-24 03:55PM
07:30AM
May-31-24 07:30AM
May-29-24 05:30AM
May-28-24 06:04AM
May-20-24 11:04AM
06:00AM
May-14-24 07:08AM
May-10-24 01:03PM
12:26PM
11:32AM
May-09-24 11:54PM
04:34PM
04:14PM
04:01PM
May-03-24 07:26AM
May-02-24 04:01PM
Apr-29-24 07:30AM
Apr-26-24 07:30AM
Apr-24-24 04:01PM
07:30AM
Apr-16-24 09:00AM
Apr-07-24 09:00AM
Apr-04-24 01:27AM
Apr-01-24 04:30PM
Mar-25-24 08:00AM
Mar-11-24 06:53PM
Mar-08-24 11:29PM
07:30AM
Mar-04-24 07:30AM
Feb-07-24 10:42AM
10:02AM
Feb-06-24 04:32PM
04:32PM
04:01PM
Jan-22-24 04:01PM
Jan-18-24 05:37AM
Jan-09-24 03:02AM
Jan-06-24 01:01PM
Jan-05-24 05:00PM
11:02AM
Jan-03-24 07:00AM
Dec-29-23 04:01PM
Dec-24-23 09:01AM
Dec-21-23 07:30AM
Dec-20-23 07:30AM
Dec-01-23 09:32AM
Nov-30-23 12:22PM
Nov-29-23 04:51PM
04:01PM
Nov-28-23 07:30AM
Nov-22-23 09:46PM
Nov-21-23 04:01PM
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Oliver TracieChief Commercial OfficerJul 02 '24Sale25.289,394237,480127,107Jul 03 05:27 PM
Vakiener VictoriaDirectorMay 02 '24Sale23.311,79941,93530,205May 06 06:04 PM
Hamilton James CChief Discovery/Trans MedicineApr 01 '24Sale28.036,000168,180204,851Apr 03 06:05 PM
Lu HongboDirectorMar 19 '24Buy28.001,00028,00032,680Mar 20 07:06 PM
Lu HongboDirectorMar 20 '24Buy27.501,00027,50033,680Mar 20 07:06 PM
Lu HongboDirectorMar 18 '24Buy27.491,00027,49031,680Mar 20 07:06 PM
Myszkowski Kenneth AllenChief Financial OfficerMar 06 '24Sale35.1940,0001,407,600400,600Mar 08 05:54 PM
Anzalone Christopher RichardChief Executive OfficerJan 31 '24Option Exercise14.5457,499836,0353,772,547Feb 02 05:25 PM
Anzalone Christopher RichardChief Executive OfficerJan 31 '24Sale32.3557,4991,860,0193,715,048Feb 02 05:25 PM
Hamilton James CChief Discovery/Trans MedicineJan 12 '24Sale36.897,940292,904210,851Jan 17 06:32 PM
GIVEN DOUGLAS BDirectorJan 11 '24Sale38.062,911110,788129,711Jan 16 06:06 PM
Waddill William D.DirectorJan 11 '24Sale38.073,934149,75947,870Jan 16 06:06 PM
Ferrari MauroDirectorJan 11 '24Sale38.063,147119,78760,778Jan 16 06:06 PM
Vakiener VictoriaDirectorJan 11 '24Sale38.104,720179,81332,001Jan 16 06:06 PM
Oliver TracieChief Commercial OfficerJan 05 '24Sale33.89742,508136,501Jan 08 05:17 PM
Myszkowski Kenneth AllenChief Financial OfficerJan 05 '24Sale35.2716,104567,910440,600Jan 08 05:16 PM
San Martin JavierChief Medical OfficerJan 05 '24Sale35.268,303292,804198,497Jan 08 05:16 PM
Hamilton James CChief Discovery/Trans MedicineJan 05 '24Sale35.1832,1431,130,748218,791Jan 05 08:02 PM
Hamilton James CChief Discovery/Trans MedicineJan 03 '24Sale32.196,300202,781175,934Jan 05 08:02 PM
O'Brien PatrickCOO and General CounselJan 05 '24Sale35.2722,841805,716464,385Jan 05 07:58 PM
O'Brien PatrickCOO and General CounselJan 03 '24Sale32.288,749282,439403,826Jan 05 07:58 PM
O'Brien PatrickCOO and General CounselJan 04 '24Sale32.631,60052,208402,226Jan 05 07:58 PM
Anzalone Christopher RichardChief Executive OfficerJan 02 '24Sale31.019,952308,6373,715,048Jan 04 05:25 PM
Anzalone Christopher RichardChief Executive OfficerDec 20 '23Sale28.5412,000342,4803,725,000Dec 22 05:04 PM